Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study

other OA: closed public-domain-us
View on PubMed View at publisher

Abstract

Deep endometriosis involvement of the bladder is uncommon but it is symptomatic in most of the cases. Although laparoscopic excision is very effective, some patients with no pregnancy desire require a medical approach. We performed a pilot study on the effect of a new progestin dienogest on bladder endometriosis. Six patients were treated for 12 months with dienogest 2 mg/daily. Pain, urinary symptoms, quality of life, nodule volume and side effects were recorded. During treatment, symptoms improved very quickly and the nodules exhibit a remarkable reduction in size. Dienogest may be an alternative approach to bladder endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosisbladder_endometriosis

MeSH descriptors

Endometriosis Hormone Antagonists Nandrolone Urinary Bladder Diseases Adult Cohort Studies Dysuria Endometriosis Endometriosis Female Hematuria Hormone Antagonists Humans Nandrolone Nandrolone Pilot Projects Quality of Life Treatment Outcome Ultrasonography Urinary Bladder Diseases

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
pubmed
last seen: 2026-05-13T22:17:58.238279+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine